As the information in this release pertains to EDEN RESEARCH PLC, this announcement is deemed to constitute inside information as stipulated under the retained EU law version of the Market Abuse Regulation (EU) No. 596/2014 (the "UK MAR") which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. The information is disclosed in accordance with the Company's obligations under Article 17 of the UK MAR. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
|
|
Eden Research and Corteva Agriscience Announce Ecovelex?2023 Approval in Italy
The innovative seed treatment helps farmers safely repel birds
Cremona, Italy and Abingdon, UK - December 18, 2023 - Corteva Agriscience and Eden Research are pleased to announce that Ecovelex? 2023 has been granted, according to Reg. EU/1107/2009, a temporary approval in Italy for use as a bird repellent seed treatment in corn for the 2024 growing season. Eden is an AIM listed company that develops and supplies sustainable solutions for crop protection, animal health and consumer products.
Developed by Corteva and Eden, Ecovelex represents a new entrant into the seed treatment market and is an alternative to conventional chemicals that are not approved in the EU and UK. It was developed to safely tackle crop destruction caused by birds - a major cause of losses in maize and other crops.
Ecovelex works by creating an unpleasant taste or odour that repels birds, leaving the seeds safely intact and the birds unaffected and free to find alternative food sources.
The product is based on Eden's plant-derived chemistry, registered in the EU, U.S. and elsewhere, and formulated using Eden's Sustaine® microencapsulation system. It is designed to support farmers as they strive to meet consumer and regulatory demands for more sustainable agriculture.
Leonardo Costa, EMEA Seed Applied Technologies Leader at Corteva Agriscience, said, "We are pleased to announce that farmers in Italy will have the opportunity to use maize seed that has been treated with Ecovelex to help control the damage frequently caused by birds. Ecovelex is a safe, effective and sustainable alternative to conventional crop protection products. Every year, farmers face heavy losses caused by birds, and recent regulatory changes have meant that the conventional approaches to combating crop damage are no longer available.
"This represents a huge step forward in sustainable plant chemistry. Eden's team has done an excellent job of helping us tackle one of the tremendous challenges faced by today's farmers, and we look forward to expanding upon this work in the future."
Sean Smith, Eden CEO, said, "Eden's collaboration with Corteva Agriscience over the past several years has been highly productive, and I am pleased to see the first real-world benefits from these activities supporting farmers' requirements in Italy.
"Together, we are bringing another safe and effective product to market in near record time through efficient, open collaboration. This is ultimately a win for farmers who will have a new, effective tool for improving crop yields, safely and sustainably."
Eden has submitted the regulatory dossier and application to Austria, which will act as the interzonal rapporteur member state on behalf of the EU. Review and authorisation can take between 18 and 24 months, with each EU member state then able to ratify the authorisation or require additional information before granting local authorisations.
Notes to Editors:
About Eden
Eden is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Eden's products are formulated with terpene active ingredients, based on natural plant defence metabolites. To date, they have been primarily used on high-value fruits and vegetables, improving crop yields and marketability, with equal or better performance when compared with conventional pesticides. Eden was admitted to trading on AIM on 11 May 2012 and trades under the symbol EDEN. It was awarded the London Stock Exchange Green Economy Mark in January 2021, which recognises London-listed companies that derive over 50% of their total annual revenue from products and services that contribute to the global green economy. Eden derives 100% of its total annual revenues from sustainable products and services.
For more information, please visit: www.edenresearch.com.
Follow Eden on LinkedIn, Twitter and YouTube.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfils its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Follow Corteva on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Contacts
Eden Research plc | |
Sean Smith | +44 (0) 1285 359 555
|
Cavendish Capital Markets Limited (Nominated advisor and broker) | |
Giles Balleny / George Lawson (corporate finance)
| +44 (0) 20 7220 0500 |
| |
Hawthorn Advisors (Financial PR to Eden Research plc) | |
Simon Woods Victoria Ainsworth
|
|
| |
Corteva Media Enquiries | |
József Máté, Corporate Communications Leader, EMEA
| jozsef.mate@corteva.com +41 79 597 2709 |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.